News
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
16h
Zacks Investment Research on MSNMRNA Stock Jumps on CDC's Revised RSV Vaccine RecommendationsShares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...
1d
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotThe new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
1d
Stocktwits on MSNCDC Greenlights Vaccines From Pfizer, Moderna, GSK Amid Shakeup Of Advisory PanelThe Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results